Sanofi
SNY
SNY
716 hedge funds and large institutions have $12.8B invested in Sanofi in 2024 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 247 increasing their positions, 278 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
716
Holders Change
-30
Holders Change %
-4.02%
% of All Funds
9.53%
Holding in Top 10
11
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-15.38%
% of All Funds
0.15%
New
77
Increased
247
Reduced
278
Closed
91
Calls
$94.5M
Puts
$74.6M
Net Calls
+$19.9M
Net Calls Change
-$9.54M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$246M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$121M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$82.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$36.8M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$371M |
| 2 |
Bank of New York Mellon
New York
|
-$315M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$176M |
| 4 |
BlackRock
New York
|
-$128M |
| 5 |
Millennium Management
New York
|
-$118M |